Erlotinib vs Sacituzumab Govitecan

## Erlotinib vs Sacituzumab Govitecan: Overview

This comparison examines the pharmacological differences between **Erlotinib** and **Sacituzumab Govitecan**.

## Mechanism of Action

**Erlotinib**: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

## Pharmacokinetics

**Half-life**: Erlotinib — 36 hours; Sacituzumab Govitecan — N/A.

## Chemical Properties

**Molecular Formula**: Erlotinib — C22H23N3O4; Sacituzumab Govitecan — N/A.

**Molecular Weight**: Erlotinib — 393.4380 g/mol; Sacituzumab Govitecan — N/A.

**Type**: Erlotinib — Small molecule; Sacituzumab Govitecan — Antibody drug conjugate.